Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease

Published:2005-01 Issue:1 Volume:11 Page:47-55
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Johnston Laura J.,Brown Janice,Shizuru Judith A.,Stockerl-Goldstein Keith E.,Stuart Monic J.,Blume Karl G.,Negrin Robert S.,Chao Nelson J.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference39 articles.

1. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease;Sullivan;Blood,1988

2. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease;Sullivan;Blood,1988

3. Therapy for chronic graft-versus-host disease;Koc;Blood,2002

4. Traditional treatment of chronic graft-versus-host disease;Flowers;Blood Marrow Transplant Rev.,2002

5. Development of a prognostic model for grading chronic graft-versus-host disease;Akpek;Blood,2001

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study;Bone Marrow Transplantation;2024-05-02

2. Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development;Current Oncology;2024-03-08

3. Diagnosis;Oral Lichen Planus and Lichenoid Lesions;2023

4. Insights and strategies to promote immune tolerance in allogeneic hematopoietic stem cell transplantation recipients;Translational Autoimmunity;2023

5. Chronic graft-versus-host disease. Part II: disease activity grading and therapeutic management;Journal of the American Academy of Dermatology;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3